Research/art/teacher profile of a person
Name and surname:
prof. PharmDr. Ján Klimas, PhD., MPH
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Klimas
I.2 - Name
Jan
I.3 - Degrees
Prof, PharmD, PhD, MPH
I.4 - Year of birth
1976
I.5 - Name of the workplace
Department of Pharmacology and Toxicology, Faculty of Pharmacy, CU Bratislava
I.6 - Address of the workplace
Ul. odbojarov 10, 832 32 Bratislava
I.7 - Position
Professor
I.8 - E-mail address
jan.klimas@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/3726?do=filterForm-submit&name=J%C3%A1n&surname=Klimas&sort=surname&employment_state=yes&filter=Vyh%C4%BEada%C5%A5
I.10 - Name of the study field in which a person works at the university
Pharmacy
I.11 - ORCID iD
0000-0002-6845-2105

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy, CU Bratislava
II.b - Year
1999
II.c - Study field and programme
Pharmacy and Pharmacy
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy, CU Bratislava
II.b - Year
2006
II.c - Study field and programme
Pharmacy and Pharmacology
II.4 - Associate professor
II.a - Name of the university or institution
Jessenius Faculty of Medicine, CU Bratislava
II.b - Year
2009
II.c - Study field and programme
Pharmacy and Pharmacology
II.5 - Professor
II.a - Name of the university or institution
Comenius University Bratislava
II.b - Year
2017
II.c - Study field and programme
Pharmacy and Pharmacology
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Professor Faculty of Pharmacy, CU Bratislava 2017-present
Associate Professor Faculty of Pharmacy, CU Bratislava 2009-2017
Assistant Professor Faculty of Pharmacy, CU Bratislava 1999-2002 and 2005-2009
Wissenschaftlicher Mitarbeiter Institut für Pharmakologie und Toxikologie, Universitätsklinikum, Westfälische Wilhelms-Universität, Münster, Germany 2002-2004

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Pharmacology Pharmacy 1.+2. Pharmacy
Clinical Pharmacy Clinical Pharmacy 3. Pharmacy
Clinical Pharmacology and Pharmacotherapy Clinical Pharmacy 3. Pharmacy
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
Pharmacy 1.+2. Pharmacy
Clinical Pharmacy 3. Pharmacy
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.3.a - Name of the field of habilitation procedure and inaugural procedure V.3.b - Study field to which it is assigned
Clinical Pharmacy Pharmacy
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
1
V.4.c - Dissertation (third degree)
3
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
1
V.4.b - Diploma (second degree)
43
V.4.c - Dissertation (third degree)
7
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Innovative Medicines in Pharmacotherapy Pharmacy 1.+2. Pharmacy
Basics of Regulatory Pharmacy Pharmacy 1.+2. Pharmacy
Pharmacology Pharmacy 1.+2. Pharmacy
Clinical Pharmacology and Pharmacotherapy Pharmacy 1.+2. Pharmacy
Clinical Pharmacy and Pharmacotherapy Pharmacy 1.+2. Pharmacy

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
492
VI.1.b - Over the last six years
111
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
89
VI.1.b - Over the last six years
30
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
919
VI.1.b - Over the last six years
366
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
719
VI.1.b - Over the last six years
366
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
1
VI.1.b - Over the last six years
0
VI.2 - The most significant research/artistic/other outputs
1

Kmecova, J., Klimas, J. Heart rate correction of the QT duration in rats (2010) European Journal of Pharmacology, 641 (2-3), pp. 187-192. https://www.sciencedirect.com/science/article/abs/pii/S0014299910004887?via%3Dihub

2

Krenek, P., Kmecova, J., Kucerova, D., Bajuszova, Z., Musil, P., Gazova, A., Ochodnicky, P., Klimas, J., Kyselovic, J. Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function (2009) European Journal of Heart Failure, 11 (2), pp. 140-146. https://onlinelibrary.wiley.com/doi/full/10.1093/eurjhf/hfn026

3

Klimas, J., Olvedy, M., Ochodnicka-Mackovicova, K., Kruzliak, P., Cacanyiova, S., Kristek, F., Krenek, P., Ochodnicky, P. Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats (2015) Journal of Cellular and Molecular Medicine, 19 (8), pp. 1965-1974. https://onlinelibrary.wiley.com/doi/10.1111/jcmm.12573

4

Klimas, J., Kruzliak, P., Rabkin, S.W. Modulation of the QT interval duration in hypertension with antihypertensive treatment (2015) Hypertension Research, 38 (7), pp. 447-454. https://www.nature.com/articles/hr201530

5

Kmecova, Z., Veteskova, J., Lelkova-Zirova, K., Bies Pivackova, L., Doka, G., Malikova, E., Paulis, L., Krenek, P., Klimas, J. Disease severity-related alterations of cardiac microRNAs in experimental pulmonary hypertension (2020) Journal of Cellular and Molecular Medicine 24 (12), pp. 6943-6951. https://onlinelibrary.wiley.com/doi/10.1111/jcmm.1535

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Kmecova, Z., Veteskova, J., Lelkova-Zirova, K., Bies Pivackova, L., Doka, G., Malikova, E., Paulis, L., Krenek, P., Klimas, J. Disease severity-related alterations of cardiac microRNAs in experimental pulmonary hypertension (2020) Journal of Cellular and Molecular Medicine 24 (12), pp. 6943-6951. https://onlinelibrary.wiley.com/doi/10.1111/jcmm.1535

2

Radik, M., Kmecova, Z., Veteskova, J., Malikova, E., Doka, G., Krenek, P., Klimas, J. Hepatocyte growth factor plays a particular role in progression of overall cardiac damage in experimental pulmonary hypertension (2019) International Journal of Medical Sciences 16 (6), pp. 854-863. https://www.medsci.org/v16p0854.htm

3

Nemcekova, V., Kmecova, Z., Bies Pivackova, L., Goncalvesova, E., Krenek, P., Doka, G., Klimas, J. Hematocrit-Related Alterations of Circulating microRNA-21 Levels in Heart Failure Patients with Reduced Ejection Fraction: A Preliminary Study (2021) Genetic Testing and Molecular Biomarkers 25 (4), pp. 302-306. https://www.liebertpub.com/doi/full/10.1089/gtmb.2020.0277

4

Rajtik, T., Galis, P., Bartosova, L., Paulis, L., Goncalvesova, E., Klimas, J. Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19 (2021) International Journal of Molecular Sciences 22 (23), pp. 12800. https://www.mdpi.com/1422-0067/22/23/12800

5

Macekova, Z., Fazekas, T., Krivosova, M., Dragasek, J., Zufkova, V., Klimas, J., Snopkova, M. Identification of a Link between Suspected Metabolic Syndrome and Cognitive Impairment within Pharmaceutical Care in Adults over 75 Years of Age (2023) Healthcare (Switzerland), 2023, 11(5), pp. 718 https://www.mdpi.com/2227-9032/11/5/718

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Austin, K.M. - Trembley, M.A. - Chandler, S.F. - Sanders, S.P. - Saffitz, J.E. - Abrams, D.J. - Pu, W.T.: Nature Reviews Cardiology, vol. 16, no. 9, 2019, p. 519-537

2

Gasperetti, A. - James, C.A. - Cerrone, M. - Delmar, M. - Calkins, H. - Duru, F.: European Heart Journal, vol. 42, no. 13, 2021, p. 1231-1243

3

Tejero, J. - Shiva, S. - Gladwin, M.T.: Physiological Reviews, Vol. 99, No. 1, 2019, p. 379

4

Jiang, X. - Eales, J.M. - Scannali, D. - Nazgiewicz, A. - Prestes, P. - Maier, M. - Denniff, M. - Xu, X. - Saluja, S. - Cano-Gamez, E. - Wystrychowski, W. - Szulinska, M. - Antczak, A. - Byars, S. - Skrypnik, D. - Glyda, M. - Kró, R.- Zywiec, J. - Zukowska-Szczechowska, E. - Burrell, L.M. - Woolf, A.S. - Greenstein, A. - Bogdanski, P. - Keavney, B. - Morris, A.P. - Heagerty, A. - Williams, B. - Harrap, S.B. - Trynka, G. - Samani, N.J. - Guzik, T.J. - Charchar, F.J. - Tomaszewski, M.:European Heart Journal, Vol. 41, No. 48, 2020, p. 4588

5

Cheng, H. - Lederer, W.J.: Physiological Reviews, Vol. 88, No. 4, 2008, p. 1545

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

Project number: APVV-15-0685. Project duration: 2016-2020. Project title: Theranostic potential of components of alternative RAS in modulation of right ventricular function and dysfunction. Principal investigator.

2

Project number: VEGA 1/0195/20. Project duration: 2020-2023. Project title: Role of hepatocyte growth factor in formation and progression of diabetic cardiomyopathy electrogenesis. Principal investigator.

3

Project number: VEGA 1/0304/17. Project duration: 2017-2019 Project title: Role of HCN channels in development of diabetic cardiomyopathy and related changes of myocardial electrogenesis. Principal investigator.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
Cooperative European Medicines Development Course, Basic module 5 (Regulatory Affairs & Pharmacovigilance), Module leader Semmelweis University, Budapest, Hungary and Comenius University in Bratislava 2012-2017

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Institut für Pharmakologie und Toxikologie, Universitätsklinikum, Westfälische Wilhelms-Universität, Münster, Germany Domagkstraße 12, 48149 Münster, Germany 2002-2004 research assistant

IX. - Other relevant facts

Date of last update
2025-01-22